avapritinib
blueprint medicines
['avapritinib', 'ayvakit']
#avapritinib (#ayvakit ) improves overall survival and clinical outcomes, compared to real-world data on prior available therapies, in patients with advanced #systemicmastocytosis, according to analyses presented at (eha) 2022 congress. 
Trusted knowledge base of practical information and resources focused on treating and diagnosing rare disease.